Diuretic effect of tolvaptan in congenital heart disease Multi-center study

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2015
INTERVENTION: Tolvaptan administration CONDITION: congenital heart disease PRIMARY OUTCOME: Urine volume, body weight, water intake, volume of drainage, urine osmolality, sodium concentration of urine, electrolytes, kidney function, Cre clearance, and GFR INCLUSION CRITERIA: Patients who had water retention such as pleural effusion, ascitis, and cardiomegaly despite standard diuretic therapy and were started tolvaptan were included in the study.
Epistemonikos ID: 08db0d9690ddb10be1abae348f77afb5f3370778
First added on: Aug 23, 2024